Quantitative benefit–harm assessment for setting research priorities: the example of roflumilast for patients with COPD

Overview of attention for article published in BMC Medicine, July 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 10,905 followers.

Quantitative benefit–harm assessment for setting research priorities: ..example of roflumilast for COPD http://t.co/v8VzmAewjY #bmcmedicine

Planning an #RCT? Consider if it's worth it using a #quantitative benefit-harm assessment. Great example: http://t.co/VqKDh6pfWj #research

Milo Puhan & colleagues argue the case for quantitative benefit-harm assessments @JohnsHopkinsSPH http://t.co/tRomcIlshY

Quantitative benefit–harm assessment for setting research priorities: the example of roflumilast for patients with… http://t.co/gUPQ5nmcdv

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.